Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	47.92	65.06	90.03	139.07	123.44
Short-Term Investments	174.37	281.34	408.17	214	564.83
Cash & Short-Term Investments	222.29	346.4	498.2	353.06	688.27
Cash Growth	-35.83%	-30.47%	41.11%	-48.70%	19.31%
Accounts Receivable	41.73	37.97	40.06	17.41	10.05
Other Receivables	1.3	1	0.8	1.4	2.5
Receivables	43.03	38.97	40.86	18.81	12.55
Inventory	8.44	14.45	14.45	19.26	14.06
Prepaid Expenses	9.99	10.37	8.64	11.62	12.04
Total Current Assets	283.75	410.19	562.15	402.75	726.91
Property, Plant & Equipment	94.38	120.32	164.21	172.94	139.04
Long-Term Investments	33.66	-	-	217.15	118.53
Goodwill	118.97	118.97	118.97	118.97	118.97
Other Intangible Assets	3.43	5.13	6.83	8.53	10.23
Other Long-Term Assets	5.18	6.52	4.46	3.01	2.74
Total Assets	539.38	661.13	856.62	923.34	1,116
Accounts Payable	7.27	7.72	8.08	3.31	3.24
Accrued Expenses	20.67	20.39	24.1	22.2	18.92
Current Portion of Long-Term Debt	0.87	-	-	-	-
Current Portion of Leases	10.24	9.38	9.23	5.06	3.53
Current Income Taxes Payable	0.18	0.06	0.19	0.39	0.37
Current Unearned Revenue	55.69	48.63	64.12	80.46	73.32
Other Current Liabilities	3.15	1.84	4.07	2.39	5.82
Total Current Liabilities	98.05	88.02	109.79	113.81	105.2
Long-Term Debt	132.41	130.66	125.36	-	-
Long-Term Leases	79.15	89.39	98.77	106.69	104.33
Long-Term Unearned Revenue	27.26	44.79	58.6	98.75	163.62
Other Long-Term Liabilities	0.02	-	-	-	-
Total Liabilities	336.89	352.86	392.52	319.24	373.15
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,506	1,453	1,387	1,324	1,254
Retained Earnings	-1,304	-1,144	-919.08	-718.89	-511.61
Comprehensive Income & Other	0.17	0.22	-4.12	-1.14	0.89
Total Common Equity	202.71	308.4	464.17	603.99	743.27
Minority Interest	-0.22	-0.12	-0.07	0.11	-
Shareholders' Equity	202.49	308.28	464.1	604.1	743.27
Total Liabilities & Equity	539.38	661.13	856.62	923.34	1,116
Total Debt	222.67	229.43	233.36	111.74	107.86
Net Cash (Debt)	33.29	116.97	264.83	458.47	698.93
Net Cash Growth	-71.54%	-55.83%	-42.23%	-34.41%	8.24%
Net Cash Per Share	0.23	0.81	1.86	3.27	5.33
Filing Date Shares Outstanding	148.58	145.09	143.23	141.58	139.22
Total Common Shares Outstanding	147.77	145.08	143.11	141.39	137.65
Working Capital	185.7	322.17	452.36	288.94	621.72
Book Value Per Share	1.37	2.13	3.24	4.27	5.40
Tangible Book Value	80.31	184.3	338.37	476.49	614.07
Tangible Book Value Per Share	0.54	1.27	2.36	3.37	4.46
Machinery	59.33	61.36	56.7	48.88	34.08
Construction In Progress	2.57	3.41	7.63	5.66	7.19
Leasehold Improvements	73.28	74.73	72.4	65.96	21.95

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q